| Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer’s disease B Le Droumaguet, J Nicolas, D Brambilla, S Mura, A Maksimenko, ... ACS nano 6 (7), 5866-5879, 2012 | 163 | 2012 |
| Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: Implications for therapy of … L Bana, S Minniti, E Salvati, S Sesana, V Zambelli, A Cagnotto, A Orlando, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (7), 1583-1590, 2014 | 151 | 2014 |
| Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model E Salvati, F Re, S Sesana, I Cambianica, G Sancini, M Masserini, ... International journal of nanomedicine, 1749-1758, 2013 | 124 | 2013 |
| Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide F Re, I Cambianica, S Sesana, E Salvati, A Cagnotto, M Salmona, ... Journal of biotechnology 156 (4), 341-346, 2011 | 123 | 2011 |
| A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer’s disease V Parthsarathy, PL McClean, C Hölscher, M Taylor, C Tinker, G Jones, ... PloS one 8 (1), e54769, 2013 | 108 | 2013 |
| Nanosensors for early cancer detection and for therapeutic drug monitoring E Salvati, F Stellacci, S Krol Nanomedicine 10 (23), 3495-3512, 2015 | 69 | 2015 |
| Ceramides and sphingomyelinases in senile plaques M Panchal, M Gaudin, AN Lazar, E Salvati, I Rivals, S Ayciriex, ... Neurobiology of Disease 65, 193-201, 2014 | 61 | 2014 |
| Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide M Gregori, M Taylor, E Salvati, F Re, S Mancini, C Balducci, G Forloni, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (2), 723-732, 2017 | 60 | 2017 |
| Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide G Sancini, M Gregori, E Salvati, I Cambianica, F Re, F Ornaghi, M Canovi, ... Journal of Nanomedicine & Nanotechnology 4 (3), 1-8, 2013 | 59 | 2013 |
| Serotonin and catecholamines in the development and progression of heart valve diseases E Goldberg, JB Grau, JH Fortier, E Salvati, RJ Levy, G Ferrari Cardiovascular research 113 (8), 849-857, 2017 | 37 | 2017 |
| Multifunctional liposomes interact with Abeta in human biological fluids: therapeutic implications for Alzheimer's disease E Conti, M Gregori, I Radice, F Da Re, D Grana, F Re, E Salvati, ... Neurochemistry international 108, 60-65, 2017 | 31 | 2017 |
| Novel antitransferrin receptor antibodies improve the blood–brain barrier crossing efficacy of immunoliposomes M Gregori, A Orlando, F Re, S Sesana, L Nardo, D Salerno, F Mantegazza, ... Journal of pharmaceutical sciences 105 (1), 276-283, 2016 | 31 | 2016 |
| FM19G11-loaded gold nanoparticles enhance the proliferation and self-renewal of ependymal stem progenitor cells derived from ALS mice S Marcuzzo, D Isaia, S Bonanno, C Malacarne, P Cavalcante, A Zacheo, ... Cells 8 (3), 279, 2019 | 24 | 2019 |
| pH-Mediated molecular differentiation for fluorimetric quantification of chemotherapeutic drugs in human plasma LA Serrano, Y Yang, E Salvati, F Stellacci, S Krol, S Guldin Chemical communications 54 (12), 1485-1488, 2018 | 12 | 2018 |
| Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation E Castillero, E Fitzpatrick, SJ Keeney, AM D’Angelo, BB Pressly, ... Science translational medicine 15 (677), eadc9606, 2023 | 5 | 2023 |
| Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide E Salvati, M Masserini, S Sesana, S Sonnino, F Re, M Gregori J Alzheimers Dis 29 (Suppl 1), 33-36, 2012 | 3 | 2012 |
| Multi-functionalized nanoparticles for therapy and diagnosis of alzheimer's disease E Salvati Università degli Studi di Milano-Bicocca, 2013 | 2 | 2013 |
| Inhibition and down regulation of the serotonin transporter contribute to the progression of degenerative mitral regurgitation RJ Levy, E Fitzpatrick, E Castillero, HJ Shukla, VV Inamdar, AE Aghali, ... bioRxiv, 2020.03. 10.985382, 2020 | 1 | 2020 |
| Nanoliposomes functionalized to overcome the blood-brain barrier and to target amyloid-βpeptide: the chemical design affects the permeability across a model barrier E Salvati, F Re, S Sesana, I Cambianica, G Sancini, M Masserini, ... Multi-functionalized nanoparticles for therapy and diagnosis of Alzheimer’s …, 2010 | 1 | 2010 |
| Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease S Mancini, C Balducci, M Gregori, E Salvati, G Sancini, L Colombo, ... | | 2015 |
